function getval(val){
 var a1=val.replace(/<\/?.+?>/g,"");
 var a2=a1.replace(/ /g,"");
 return a2;
}
//document.write('http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/910.html');
wx.config({
debug:  false, 
appId: 'wx85d01b1d7184c45d',
timestamp: 1716286214,
nonceStr: 'LYBAunEiATYEuJp7',
signature: '88869e64da7f8218d6dec5d2eef5fe1939303f48',
jsApiList: [ 
   'checkJsApi', 
   'onMenuShareTimeline', 
   'onMenuShareAppMessage', 
   'onMenuShareQQ', 
   'onMenuShareWeibo'
]
});
wx.ready(function () { 
	wx.onMenuShareTimeline({  
	title: 'PARP抑制剂的前世今生｜从“基础”到“临床”', 
	link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/910.html',
	imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
	success: function () {
		//alert('fx-ok');
	},
	cancel: function () {
		//alert('fx-no');
	}
	});
	wx.onMenuShareAppMessage({  
		title: 'PARP抑制剂的前世今生｜从“基础”到“临床”', 
		link: 'http://wxzl.cogonline.com/html/CeShiZhuanLanYi/ShiBin/ZhiNaWenXian/910.html',
		imgUrl: 'http://wxzl.cogonline.com/wp/logo.jpg',
		desc: getval('前期我们介绍了PARPi波折的研发历程，历经三次药物结构的更迭，才得以上市。临床前数据显示，尼拉帕利凭借其独特的“开环结构”，使其具有“高溶解性、高透膜性”的药学特性，助力其强效的临床前抗肿瘤活性。本期OC文献精读特别邀请来自山西省肿瘤医院的赵宏伟医生，介绍PARP抑制剂的前世今生：“从基础走向临床”系列文章。            00:000:00            '),
		success: function () {
			//alert('fx-ok');
		},
		cancel: function () {
			//alert('fx-no');
		}
	});
});	
wx.error(function (res) {
	//alert(location.href.split('#')[0]);
	//alert('err:'+res.errMsg);  
});
if(location.href.indexOf("?") >= 1 ){
	location.href=location.href.substring(0,location.href.indexOf("?"));
}